Viatris VTRS 深沪

等待开盘 08-21 09:30:00 美东时间

16.125

-0.120

-0.74%

华盛通

立即下载

最高16.26
今开16.13
成交量 298.94万股
最低 16.04
昨收 16.245
总市值 185.21亿
52周最高 18.39
市盈率 ^静 --
换手率 0.26%
52周最低 9.065
委比 -10.61%
总股本 11.49亿
历史最高 18.39
量比 0.37
振幅 1.35%
历史最低 6.25
每手 1
风险率 2.70%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

财报速睇 | Viatris, Inc. 2026财年Q2营收37.57亿美元，同比增长4.9%；归母净利润亏损1.19亿美元，同比亏损扩大2280.0%

华盛资讯8月7日讯，Viatris, Inc.公布2026财年Q2业绩，公司Q2营收37.57亿美元，同比增长4.9%，归母净利润亏损1.19亿美元，同比亏损扩大2280.0%。

08-07 12:17
财报速睇 | Viatris, Inc. 2026财年Q2营收37.57亿美元，同比增长4.9%；归母净利润亏损1.19亿美元，同比亏损扩大2482.6%

华盛资讯8月6日讯，Viatris, Inc.公布2026财年Q2业绩，公司Q2营收37.57亿美元，同比增长4.9%，归母净利润亏损1.19亿美元，同比亏损扩大2482.6%。

08-06 21:07
Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

Harrow has agreed to acquire TYRVAYA, a nasal spray for dry eye disease, from Viatris for up to $100 million. TYRVAYA, approved in the U.S., China, and Taiwan, offers a different mechanism of action compared to Harrow's VEVYE, addressing tear production without eye drop side effects. The acquisition expands Harrow's dry eye portfolio, providing more treatment options for patients and enhancing its market position.

08-06 11:00
Viatris Announces Quarterly Dividend

PITTSBURGH, Aug. 4, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on August 3, 2026, its Board of Directors declared a quarterly dividend of $0.12 per share for each ...

08-04 18:59
Stock index futures edge up as positive sentiment continues

Stock index futures were higher before the bell Tuesday as investors carried over positive sentiment from the previous session's broad market rally. Nasdaq 100 futures (US100:IND) rose +0.41%, S&P 500...

08-04 15:09
July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreat

The healthcare sector (XLV) gained about 2.45% in July, outperforming the broader S&P 500 (SPY), which slipped around 0.12% during the month. Company-specific earnings and catalysts drove stock perfor...

08-01 23:05
Viatris gains approval of Gwyn Lo contraceptive patch

The US FDA has approved Viatris' (VTRS) Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system) contraceptive patch. Gwyn Lo is applied weekly for three consecutive weeks, and then one patch...

07-29 22:57
默克(MRK)与Viatris等7家药企达成自愿许可协议推进新型HIV预防药物阿利马曲全球可及性

金吾资讯

07-24 21:16
Viatris Receives EMA CHMP Recommendation For Approval Of Ruxolitinib Viatris For The Treatment Of Myelofibrosis, Polycythaemia Vera And Graft-Vs-Host Disease

https://www.ema.europa.eu/en/medicines/human/EPAR/ruxolitinib-viatris

07-24 18:35

派息除权日	每股总股息	派息日期
2026-08-21	0.12	2026-09-16
2026-05-22	0.12	2026-06-17
2026-03-09	0.12	2026-03-18
2025-11-24	0.12	2025-12-15
2025-08-22	0.12	2025-09-15
2025-05-23	0.12	2025-06-16
2025-03-10	0.12	2025-03-18
2024-11-22	0.12	2024-12-13
2024-08-23	0.12	2024-09-13
2024-05-23	0.12	2024-06-14
2024-03-08	0.12	2024-03-18
2023-11-22	0.12	2023-12-15
2023-08-23	0.12	2023-09-15
2023-05-23	0.12	2023-06-16
2023-03-08	0.12	2023-03-17
2022-11-22	0.12	2022-12-16
2022-08-23	0.12	2022-09-16
2022-05-23	0.12	2022-06-16
2022-02-23	0.12	2022-03-16
2021-11-22	0.11	2021-12-16
2021-08-23	0.11	2021-09-16
2021-05-21	0.11	2021-06-16
2007-06-27	0.06	2007-07-16
2007-03-28	0.06	2007-04-16
2006-12-27	0.06	2007-01-16
2006-09-27	0.06	2006-10-16
2006-06-28	0.06	2006-07-14
2006-03-29	0.06	2006-04-17
2005-12-28	0.06	2006-01-13
2005-09-28	0.06	2005-10-17
2005-06-28	0.06	2005-07-15
2005-03-29	0.03	2005-04-15
2004-12-29	0.03	2005-01-14
2004-09-28	0.03	2004-10-15
2004-06-28	0.03	2004-07-15
2004-03-29	0.03	2004-04-15
2003-12-29	0.03	2004-01-15
2003-09-26	0.03	2003-10-15
2003-06-26	0.03	2003-07-15
2003-03-27	0.03	2003-04-15
2002-12-27	0.05	2003-01-15
2002-09-26	0.04	2002-10-15
2002-06-26	0.04	2002-07-15
2002-03-26	0.04	2002-04-15
2001-12-27	0.04	2002-01-15
2001-09-26	0.04	2001-10-15
2001-06-27	0.04	2001-07-16
2001-03-28	0.04	2001-04-16
2000-12-27	0.04	2001-01-15
2000-09-27	0.04	2000-10-15
2000-06-28	0.04	2000-07-15
2000-03-29	0.04	2000-04-15
1999-12-29	0.04	2000-01-14
1999-09-28	0.04	1999-10-15
1999-06-28	0.04	1999-07-15
1999-03-29	0.04	1999-04-15
1998-12-29	0.04	1999-01-15
1998-09-28	0.04	1998-10-15
1998-06-26	0.04	1998-07-15
1998-03-30	0.04	1998-04-15
1997-12-29	0.04	1998-01-15
1997-09-26	0.04	1997-10-15
1997-06-26	0.04	1997-07-15
1997-03-26	0.04	1997-04-15
1996-12-30	0.04	1997-01-15
1996-09-26	0.04	1996-10-15
1996-06-26	0.04	1996-07-15
1996-03-27	0.04	1996-04-15
1995-12-27	0.04	1996-01-15
1995-09-27	0.04	1995-10-13
1995-06-29	0.05	1995-07-14
1995-03-27	0.05	1995-04-13
1994-12-23	0.05	1995-01-13
1994-09-26	0.05	1994-10-14
1994-06-24	0.04	1994-07-15
1994-03-25	0.04	1994-04-15
1993-12-27	0.04	1994-01-14
1993-09-24	0.04	1993-10-15
1993-06-24	0.03	1993-07-15
1993-03-25	0.03	1993-04-15
1992-12-24	0.03	1993-01-15
1992-09-24	0.03	1992-10-15
1992-06-24	0.05	1992-07-15
1992-03-25	0.05	1992-04-15
1991-12-24	0.05	1992-01-15
1991-09-24	0.05	1991-10-15
1991-06-24	0.05	1991-07-15
1991-03-22	0.05	1991-04-15
1990-12-24	0.05	1991-01-15
1990-09-24	0.05	1990-10-15
1990-06-25	0.05	1990-07-16
1989-12-22	0.05	1990-01-15
1989-06-26	0.05	1989-07-17
1988-12-23	0.05	1989-01-16
1988-06-29	0.05	1988-07-15
1987-12-24	0.05	1988-01-15
1987-06-24	0.05	1987-07-15
1986-12-24	0.05	1987-01-15
1986-06-24	0.05	1986-07-15
1985-12-27	0.05	1986-01-15
1985-06-24	0.05	1985-07-19
1984-12-24	0.10	1985-01-15
1984-05-21	0.05	1984-06-13
1983-07-11	0.05	1983-08-12
1981-11-16	1.00	1981-11-13

公司名称	Viatris
行业分类	--
业务描述	Viatris Inc.于2019年2月14日在特拉华州成立。该公司的业务在医药产品的商业化和制造方面处于全球领先地位，拥有20个全球公认的医药品牌以及一个美国的仿制药平台Greenstone。

Viatris VTRS 深 沪

16.125

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Viatris VTRS 深沪